Clinical Study 3 Underway

clinical study on prostrate cancer - calderahealth

This pivotal study is designed to test the accuracy of the gene signatures from CS2b generated on prostate tissue in urine, allowing for the development of a highly accurate prostate cancer screening test that utilises the non-invasive sample source of urine. In total, Caldera will recruit a minimum of 300 donors who will donate matched urine and biopsy tissue samples.